Pharmaceutical Executive Europe - April 2008 - (Page 13) Pharmaceutical Executive Europe April 2008 Calendar 13 Pharmaceutical Market Research Conference 25–27 JUNE • Barcelona, Spain Martin Child/Getty Images manchester 3rd Annual Biomarkers Congress Allan Baxter/Getty Images This year’s EphMRA conference and agency fair is entitled ‘A Night at the Movies’ and will present sessions such as ‘Mission Impossible: Winning the Hearts and Minds of New Customers,’ ‘Back to the Future: A Scientific Approach to Pharma Advertising,’ and ‘What Lies Beneath: Advanced Qualitative Techniques to Really Understand the Consumer.’ Contact Janet Henson +41 21 825 4954 Email conference@ephmra.org Web www.ephmra.org 14–15 MAY • The Midland Hotel, Manchester This event explores core topics such as integration of applications and enabling technologies, molecular diagnostics and assay development, imaging in preclinical and clinical development; biomarker discovery and validation in different therapeutic areas such as oncology, CNS and cardiovascular, infectious diseases, biomarkers in translational discovery and clinical development as well as toxicity biomarkers. Web www.biomarkers-congress.com Pharmaceutical Regulatory Affairs in China 30 JUNE–1 JULY • The Rembrandt Hotel, London This seminar will provide up-to-date coverage of all aspects playing an important role in gaining and maintaining a successful marketing authorisation for R&D based pharmaceutical products in PR China. Speakers will cover the underlying official regulatory sources and share the interpretation and practical aspects of putting these into practice in a day-to-day scenario. Email info@management-forum.co.uk Web www.management-forum.co.uk Generics, Supergenerics and Patient Strategies 12–13 MAY • Crowne Plaza Hotel, London With many key blockbuster drugs coming off patent in the next few years, there’s never been a better time to understand the generics industry and market. SMi’s 11th annual Generics, Supergenerics and Patent Strategies conference will address why markets like Ireland, Belgium and Spain have such low generic uptake in comparison to others such as Germany or the UK, and look at how generic competition affects pricing and reimbursement for both generic and innovative producers. Contact Alia Malick Email Alia.Malick@smi-online.co.uk Web www.smi-online.co.uk Uyen Le/Getty Images http://www.ephmra.org http://www.biomarkers-congress.com http://www.management-forum.co.uk http://www.smi-online.co.uk
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.